Table 2.
Total (n = 33) | No seizure (n = 22) | Seizure (n = 11) | ||||
---|---|---|---|---|---|---|
Interval from arrest to target temperature (h) | 7 | 5 | 7 | 5 | 8 | 7 |
Time at target temperature (h) | 24 | 5 | 24 | 5 | 23 | 6 |
Duration of rewarming (h) | 8 | 3 | 8 | 4 | 8 | 4 |
Interval from arrest to cvEEG monitoring initiation (h) | 7 | 3 | 8 | 4 | 7 | 2 |
Glasgow coma score | ||||||
Eyes | 1 | 0 | 1 | 0 | 1 | 0 |
Verbal | 1 | 0 | 1 | 0 | 1 | 0 |
Motor | 1 | 2 | 1 | 2 | 1 | 0 |
Methods of cooling | ||||||
Endovascular coolinga | 22 | 66.7% | 13 | 59.1% | 9 | 81.8% |
Surface coolinga | 27 | 81.8% | 18 | 81.8% | 9 | 81.8% |
Surface and endovascular coolinga | 19 | 57.6% | 12 | 54.5% | 7 | 63.6% |
Any sedation | 30 | 90.9% | 19 | 86.4% | 11 | 100.0% |
Midazolam | 14 | 42.4% | 7 | 31.8% | 7 | 63.6% |
Lorazepam | 5 | 15.2% | 1 | 4.5% | 4 | 36.4% |
Propofol | 24 | 72.7% | 15 | 68.2% | 9 | 81.8% |
Patients could have multiple methods of cooling.